VALUE-DX

VALUE-DX

Start Date:

April 2019

End Date:

September 2024

Duration:

54 months

ID-CARE Role:

Website:

https://value-dx.eu

Partner, Work Package (WP) Leader

Description

Title: The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use

Design:

Systematic reviews of the existing evidence for community-acquired acute respiratory tract infections (CA-ARTI) diagnostic tests
Integration of data from stakeholders’ consultation using multi-criteria decision analyses
Machine-learning-driven clinical algorithm development

Primary Objective: to develop clinical algorithms for the diagnosis of CA-ARTI.

Partners

University of Antwerp - BELGIUM (Coordinator)

PENTA Fondazione PENTA - ITALY

RAMBAM The Health Corporation - ISREAL

UNIRIOJA Universidad De La Rioja - SPAIN

UMCG University Medical Center Groningen - NETHERLANDS

UMCU University Medical Center Utrecht - NETHERLANDS

UK University of Edinburgh - UK

OX University of Oxford - UK

UNIVR University of Verona - ITALY

Sponsor

Publications

Clinical Microbiology and Infection

01/12/22

Perpetual observational studies: new strategies to support efficient implementation of observational studies and randomized trials in infectious diseases

Learn More

International Journal of Infectious Diseases

31/08/20

Multi-criteria decision analysis to prioritize hospital admission of patients affected by COVID-19 in low-resource settings with hospital-bed shortage

Learn More

Clinical Microbiology and Infection

30/09/21

Diagnostic accuracy of point-of-care tests in acute community-acquired lower respiratory tract infections. A systematic review and meta-analysis

Learn More

Clinical Microbiology and Infection

28/02/21

Nucleic acid amplification tests on respiratory samples for the diagnosis of coronavirus infections: a systematic review and meta-analysis

Learn More